An Update on Hepatitis B & C
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
4/7/2020: 12:00 AM
Ends On:
6/30/2020: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Professor of Medicine
Division of Gastroenterology
Financial Relationships
Consulting/ Advisory Committees: AbbVie, Takeda Pharmaceuticals, Centene Corporation, Medimpact, Merck & Company, Transplant Management Group
Speakers' Bureaus/Honoraria: AbbVie, Pfizer, Inc,, Dova Pharmaceuticals, Intercept, Salix, Merck & Company, Gilead Sciences, Inc
Owership Interest/Stock Equity: AbbVie,
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 17th Galaxy of Gastroenterology, November 1-2, 2019, which was supported in part by Takeda Pharmaceuticals Salix Pharmaceuticals, Inc. A Division of Bausch Health US and LLC Olympus Corporation of the Americas.
Course Chair
Financial Relationships:
Consulting/ Advisory Committees: Medtronic, Ironwood Pharmaceuticals, Isothrive, Torax, Quintiles
Research Support/Grants: Allergan, Inc, Ironwood Pharmaceuticals, Impleo Medical Inc, Phathom Pharmaceuticals
Speakers' Bureaus/Honoraria: Diversitak, Medtronic, Sierra Scientific/Given Imaging/Covidien/Medtroni
Gregory S. Sayuk, MD, MPH, Course Chair
Financial Relationships: Reviewer has nothing to disclose
Jill Elwing, MD, Independent Reviewer
Financial Relationships: Reviewer has nothing to disclose
Laura Haroian, RN, MSN, Nurse Planner
Financial Relationships: Planner has nothing to disclose.
Gillian M. Powderly, PharmD, Pharmacist Planner
VA St. Louis Health Care System-John Cochran Division
Financial Relationships: Planner has nothing to disclose.
Faculty
Jeffrey S. Crippin, MDProfessor of Medicine
Division of Gastroenterology
Financial Relationships
Consulting/ Advisory Committees: AbbVie, Takeda Pharmaceuticals, Centene Corporation, Medimpact, Merck & Company, Transplant Management Group
Speakers' Bureaus/Honoraria: AbbVie, Pfizer, Inc,, Dova Pharmaceuticals, Intercept, Salix, Merck & Company, Gilead Sciences, Inc
Owership Interest/Stock Equity: AbbVie,
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 17th Galaxy of Gastroenterology, November 1-2, 2019, which was supported in part by Takeda Pharmaceuticals Salix Pharmaceuticals, Inc. A Division of Bausch Health US and LLC Olympus Corporation of the Americas.
Planning Committee
C. Prakash Gyawali, MD, MRCPCourse Chair
Financial Relationships:
Consulting/ Advisory Committees: Medtronic, Ironwood Pharmaceuticals, Isothrive, Torax, Quintiles
Research Support/Grants: Allergan, Inc, Ironwood Pharmaceuticals, Impleo Medical Inc, Phathom Pharmaceuticals
Speakers' Bureaus/Honoraria: Diversitak, Medtronic, Sierra Scientific/Given Imaging/Covidien/Medtroni
Gregory S. Sayuk, MD, MPH, Course Chair
Financial Relationships: Reviewer has nothing to disclose
Jill Elwing, MD, Independent Reviewer
Financial Relationships: Reviewer has nothing to disclose
Laura Haroian, RN, MSN, Nurse Planner
Financial Relationships: Planner has nothing to disclose.
Gillian M. Powderly, PharmD, Pharmacist Planner
VA St. Louis Health Care System-John Cochran Division
Financial Relationships: Planner has nothing to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Discuss the risk factors for reactivation of chronic hepatitis B infection.
- Explain potential uses of hepatitis C positive donor organs.
- Describe the potential risk of using antiviral therapy containing a protease inhibitor in patients with chronic hepatitis C.
Additional Information:
Target Audience: This course is designed for primary care physicians, gastroenterologists, gastrointestinal surgeons and their associates who participate in the care of patients with gastrointestinal and hepatic disorders.
Publication Date: April 7, 2020
Expiration Date: June 30, 2020
Target Audience: This course is designed for primary care physicians, gastroenterologists, gastrointestinal surgeons and their associates who participate in the care of patients with gastrointestinal and hepatic disorders.
Publication Date: April 7, 2020
Expiration Date: June 30, 2020
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- Liu C-J, et al. Gastroenterology 2018; 154:989
- Loomba R, et al. Gastroenterology 2017; 152:1297
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
